Virtual trials became a necessity during the COVID-19 pandemic. The clinical research industry suffered mass disruption as a result (i.e., site closures & costly delays). Fortunately, ObvioHealth had been designing and conducting fully virtual and decentralized studies well the pandemic. Our presentation recaps lessons learned from 4+ years and 35+ decentralized clinical trials.